Variables | With deterioration (n=70) | Without deterioration (n=657) | P-value | Age, years, mean±SD | 59.91±15.29 | 59.71±15.72 | 0.920 | Sex, male/female | 38/32 | 328/329 | 0.490 | Main pulmonary artery embolism (+/-),n (%) | 43 (61.4) | 135 (20.5) | <0.001 | Saddle main pulmonary artery embolism (+/-), n (%) | 14 (20.2) | 37 (5.6) | <0.001 | Bova I, n (%) | 25 (35.7) | 560 (85.2) | <0.001 | Bova II, n (%) | 16 (22.9) | 70 (10.7) | 0.002 | Bova III, n (%) | 29 (41.4) | 27 (4.1) | <0.001 | Risk stratification (low risk), n (%) | 12 (17.1) | 132 (20.1) | 0.560 | Risk stratification (intermediate-low risk), n (%) | 11 (15.7) | 131 (19.9) | 0.400 | Risk stratification (intermediate-high risk), n (%) | 47 (67.1) | 94 (14.3) | <0.001 |
|